This law implements new EEA regulations on medical devices in Iceland. Manufacturers of medical devices must notify the Icelandic Medicines Agency and their business partners at least six months in advance if there will be a disruption or cessation in the supply of devices that could pose a serious risk to patients or public health. Operators who receive such information must immediately pass it on to others in the supply chain, healthcare institutions, and healthcare professionals. The law also implements provisions on the European database on medical devices (Eudamed) and rules on in vitro diagnostic medical devices.